Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin (Q37392789)
Jump to navigation
Jump to search
scientific article published on 10 August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin |
scientific article published on 10 August 2009 |
Statements
1 reference
Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin (English)
1 reference
Kiat Ruxrungtham
1 reference
Somnuek Sungkanuparph
1 reference
Weerawat Manosuthi
1 reference
Preecha Tantanathip
1 reference
Wiroj Mankatitham
1 reference
Aroon Lueangniyomkul
1 reference
Supeda Thongyen
1 reference
Boonchuay Eampokarap
1 reference
Sumonmal Uttayamakul
1 reference
Pawita Suwanvattana
1 reference
Samroui Kaewsaard
1 reference
N2R Study Team
1 reference
10 August 2009
1 reference
1 reference
4545-4548
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference